NCT01722825View on ClinicalTrials.gov

Study of LY2157299 in Japanese Participants With Cancer

PHASE1CompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

November 30, 2012

Primary Completion Date

June 30, 2014

Study Completion Date

June 30, 2014

Conditions
NeoplasmsNeoplasm Metastasis
Interventions
DRUG

LY2157299

Administered orally.

Trial Locations (1)

104-0045

For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559 ) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Tokyo

All Listed Sponsors
lead

Eli Lilly and Company

INDUSTRY

NCT01722825 - Study of LY2157299 in Japanese Participants With Cancer | Biotech Hunter | Biotech Hunter